Description
“These Statements Have Not Been Evaluated By The Food And Drug Administration.
This Product Is Not Intended To Diagnose, Treat, Cure Or Prevent Any Disease.”
For Research Lab Use Only, Dry Lyophilized powder, reconstitution required. Bac water not included unless ordered.
CJC-1295 with DAC (Drug Affinity Complex) is a synthetic, long-acting analog of growth hormone-releasing hormone (GHRH) (1-29) designed to stimulate sustained, elevated pituitary growth hormone (GH) and IGF-1 secretion. By incorporating DAC technology, it binds covalently to serum albumin, extending its half-life to approximately 8 days.
Scientific Description and Mechanism of Action:
- Structure: Modified GHRH (1-29), consisting of 30 amino acids.
- DAC Technology: The addition of Drug Affinity Complex allows the peptide to bind to albumin in the bloodstream, significantly increasing its stability and half-life from minutes to days, requiring fewer injections.
- Function: It acts as a GHRH receptor agonist, stimulating the pituitary gland to produce more natural growth hormone, promoting a steady-state elevation of IGF-1.
- Pharmacokinetics: Unlike CJC-1295 without DAC (Mod GRF 1-29), the DAC version provides a continuous, long-lasting release of growth hormone rather than mimicking the natural, pulsatile rhythm.
